Clinical Trials Browser

Phase 3 × OTHER_GOV × Temozolomide × Clear all

NCT06419946 2024-11-19

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

Phase 3 Not yet recruiting

Glioblastoma

NCT00268684 2006-02-28

Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis